Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-23

FDA Approved: PREGABALIN — Original Application (Creekwood Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Creekwood Pharmaceuticals LLC's Original Application (ANDA) for pregabalin, enabling a generic version of the drug. This action confirms regulatory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

ORIG AP for PREGABALIN (PREGABALIN)